FOUNDER & CHAIRMAN

Anthony is the Founder CEO and Chair of Organic Technology Holdings. As an investor and entrepreneur over the past 35 years in new technologies that have the potential to have a global impact, Anthony bought a fledgling technology in 2012 and formed OTH. The technology was originally designed to work with fish waste. Quickly realizing its potential, he surrounded himself with a respected group of scientists and like-minded investors and individuals to improve and apply a series of technology improvement to treat a variety of organic waste raw materials to create valuable and in demand end products throughout the world to be used in the human food and animal feed, nutraceutical, pharmaceutical and medical research and medical device industries.

SENIOR RESEARCH SCIENTIST & LEAD, PHD.

Maria Isabel Taborda Mejia is a Ph.D. in Biotechnology and a Biomedical Engineer with a strong passion for Industrial Biotechnology, technology development, and business innovation within the circular economy. She specializes in the development of sustainable biomaterials, with a focus on natural Hydroxyapatite (HAp) and Chitin derived from animal by-products. Her work bridges scientific research and industrial application, transforming biological waste into high-value products for use in medical, cosmetic, and agricultural industries. Currently, she contributes her expertise at Organic Technology Holdings, where she leads and supports key R&D initiatives. When she’s not in the lab or working on the next breakthrough, you’ll likely find her chasing sunshine on her bike, tackling a bouldering wall, or going for a refreshing run. Adventure and movement are her favorite ways to recharge

CHIEF SCIENTIST

Akshat Talwalkar has a highly accomplished and uniquely diverse techno-commercial profile that includes a PhD in microbiology, 10 publications in reputed scientific journals, six commercially successful patents in grain enzyme production along with extensive on-field commercial experience of new business and market development, technical sales, process development, strategic planning and key account management across Australia and the Asia Pacific region. Akshat's industrial experience includes substantial hands-on involvement with technology start-ups and large manufacturers where he led the conceptualization and development of new technologies, set up enzyme application labs and pilot plants, worked closely with both production managers and operators to successfully scale up scientifically intricate technologies from lab to production levels and worked closely with key stakeholders of large global clients to effectively transfer the developed technologies, offering continual on-site support until they were successfully integrated and established in customers production processes.

RESEARCH SCIENTIST, MSc.

Mary Sravya Kasu is a biotechnology and bioinformatics specialist currently serving as a Research Scientist at Organic Technology Holdings (OTH). Her expertise spans molecular biology, biochemical analysis, and microbial techniques, with an emphasis on experimental design, analytical validation, and process optimization. Mary holds a Master of Biotechnology and Bioinformatics from Deakin University and a Bachelor of Science in Genetics. Her current work involves hypothesis-driven research and lab-to-pilot-scale experiment execution, sample characterization using mass balance and compositional analysis, and protocol development aligned with NATA/ISO and Good Clinical Research Practice standards. She regularly interfaces with multidisciplinary teams to troubleshoot experiments, refine product formulations, and deliver client-focused R&D solutions under time-critical conditions. Her experience includes designing high-throughput lab assays, preparing technical reports for peer-reviewed and commercial use, and supervising cross-functional teams during large-scale production trials. She has contributed to multiple scientific publications, including studies on gene name misannotation and DNA methylation analysis, published in PLOS Computational Biology and Epigenetics.

CFO

Franco Giugni is a finance professional with a chartered accounting background in taxation and extensive hands-on corporate experience across a broad range of industry sectors, focused on implementing aggressive growth strategies. Franco also leads a specialist corporate advisory firm supporting larger SMEs and small-cap ASX-listed companies with mid-market M&A requirements, as well as providing investment banking services under AFSL. Within our business, Franco plays a key role in closely overseeing the Group’s rapidly expanding local and international operations.

CHIEF COMMERCIAL OFFICER

Simon Adriatico is a sales, marketing and brand professional with extensive experience across the APAC region specialising in brand development, cross border commerce and ingredient commodities trading. Having run a handful of brand and marketing agencies focussed in emerging markets, Simon has worked with several of the world’s top companies including LVMH, Volkswagen Group, IOC, Bacardi and Adidas. An early pioneer of cross border e-commerce, Simon has also developed several food & beverage and health & wellness brands in Asia and Australia. Simon is an innovator and strategic thinker with a global network encompassing a diverse range of industry sectors.